| related words |
| withdrawn |
| publication |
| researching |
| indicated |
| antibody |
| oral |
| gabapentin |
| clinically |
| riquent |
| supplying |
| melafind |
| credibility |
| implant |
| reimbursed |
| tm |
| soliris |
| reluctant |
| pti |
| allocating |
| surgeon |
|
| related documents |
| 351903--9/9/2010--EPOCH_HOLDING_CORP |
| 1333614--8/13/2009--RAZOR_RESOURCES_INC |
| 1026650--3/2/2009--ERESEARCHTECHNOLOGY_INC_/DE/ |
| 1230355--3/12/2010--TRANS1_INC |
| 1061027--3/17/2008--SUNESIS_PHARMACEUTICALS_INC |
| 1180145--3/27/2007--REPLIDYNE_INC |
| 1390478--3/31/2010--RXI_PHARMACEUTICALS_CORP |
| 937136--10/13/2006--HYPERDYNAMICS_CORP |
| 35214--9/29/2006--FERRO_CORP |
| 1132484--4/1/2010--NETEZZA_CORP |
| 730272--6/9/2006--REPLIGEN_CORP |
| 799698--4/3/2006--CYTRX_CORP |
| 881524--3/11/2009--VIVUS_INC |
| 1061027--3/30/2006--SUNESIS_PHARMACEUTICALS_INC |
| 1002637--3/8/2006--MILLENNIUM_PHARMACEUTICALS_INC |
| 72316--3/31/2009--NORD_RESOURCES_CORP |
| 1347870--3/19/2009--Monza_Ventures_Inc. |
| 35214--3/11/2009--FERRO_CORP |
| 881524--3/10/2010--VIVUS_INC |
| 1157408--9/26/2008--K12_INC |
|
| related topics |
| {product, liability, claim} |
| {interest, director, officer} |
| {product, candidate, development} |
| {system, service, information} |
| {product, market, service} |
| {regulation, government, change} |
| {capital, credit, financial} |
| {loan, real, estate} |
| {loss, insurance, financial} |
| {investment, property, distribution} |
| {tax, income, asset} |
| {gas, price, oil} |
| {cost, operation, labor} |
| {customer, product, revenue} |
| {provision, law, control} |
| {stock, price, operating} |
| {cost, contract, operation} |
| {property, intellectual, protect} |
| {competitive, industry, competition} |
| {control, financial, internal} |
|